The Effect of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Outcomes in Patients With Cancer: A Systematic Review and Meta-Analysis

Am J Cardiol. 2024 Apr 1:216:87-90. doi: 10.1016/j.amjcard.2024.01.032. Epub 2024 Feb 17.

¹ Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
² Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
³ Department of Medicine, King Edward Medical University, Lahore, Pakistan.
⁴ Cardio-Oncology Program, Medical College of Georgia at Augusta University, Augusta, Georgia.
⁵ UCLA Cardio-Oncology Program, Division of Cardiology, Department of Medicine, University of California at Los Angeles, Los Angeles, California.
⁶ Cardio-Oncology Program, The Ohio State University, Columbus, Ohio.
⁷ Inova Schar Cancer Institute and Inova Heart and Vascular Institute, Fairfax, Virginia.
⁸ Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. Electronic address: drzainasad@gmail.com.

No abstract available

Keywords: SGLT-2 inhibitors; cancer; cardiotoxicity; heart failure; meta-analysis.

Publication types